AXL-IN-13
AXL-IN-13 is a potent and orally active AXL inhibitor with an IC50 of 1.6 nM and a Kd of 0.26 nM. It exhibits anticancer activity, reverses TGF-β1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion.
Product Specifications
CAS Number
2376928-82-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
632.72
Molecular Formula
C34H41FN6O5
Notes
Research use only, not for human use.
Receptor
FLT | PDGFR | TGF-beta/Smad | TAM Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15094680 1 Vial
Lentiviral human RTP1 shRNA (UAS) - Lentiviral human RTP1 shRNA (UAS, RFP) (100)
Ask
View Details 
